Male infertility has no negative impact on IVF (in vitro fertilization) outcome if ICSI (intracytoplasmic sperm injection) is employed

2007 ◽  
Vol 88 ◽  
pp. S374-S375
Author(s):  
K.K. Volentine ◽  
L. Keskintepe
2013 ◽  
Vol 94 (1) ◽  
pp. 111-116 ◽  
Author(s):  
Bao-Guo Xie ◽  
Yuan-Hua Huang ◽  
Wei-Jie Zhu ◽  
Song Jin

Objective: To evaluate whether couples with moderate male infertility should be treated with conventional in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI). Patients and Methods: A total of 249 couples with moderate male infertility undergoing their first IVF/ICSI cycle were enrolled in the study. The couples were divided into two groups according to the results of semen analysis: moderate oligozoospermia (O group) and moderate oligoasthenozoospermia (OA group). Sibling oocytes were randomized into groups to be inseminated either by conventional IVF or ICSI. Fertilization rate, embryo quality, implantation rate, and clinical pregnancy rate were examined. Results: There was no difference in the fertilization, implantation, and pregnancy rates between conventional IVF and ICSI in either the O group or OA group (p > 0.05). Additionally, in the OA group, the good quality embryo rate was similar after IVF or ICSI (p > 0.05). However, in the O group, the good quality embryo rate was significantly higher after ICSI than after IVF (p < 0.05). Conclusions: Couples with moderate oligozoospermia or moderate oligoasthenozoospermia did not influence the major indices of IVF. Because of the uncertainties concerning the safety of ICSI, couples with moderate oligozoospermia or moderate oligoasthenozoospermia need not be subjected to this procedure.


Sign in / Sign up

Export Citation Format

Share Document